These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16045777)

  • 21. A 2-year-old baby with Downs syndrome, cryptorchidism and testicular tumour.
    Dada R; Kumar R; Kucheria K
    Eur J Med Genet; 2006; 49(3):265-8. PubMed ID: 16762828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germ cell tumours of the testis.
    Gori S; Porrozzi S; Roila F; Gatta G; De Giorgi U; Marangolo M
    Crit Rev Oncol Hematol; 2005 Feb; 53(2):141-64. PubMed ID: 15661565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas.
    Biermann K; Klingmüller D; Koch A; Pietsch T; Schorle H; Büttner R; Zhou H
    Histopathology; 2006 Sep; 49(3):290-7. PubMed ID: 16918976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spermatocytic seminoma: a review.
    Chung PW; Bayley AJ; Sweet J; Jewett MA; Tew-George B; Gospodarowicz MK; Warde PR
    Eur Urol; 2004 Apr; 45(4):495-8. PubMed ID: 15041115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Testicular cancer. Standard management leads to recovery in 90 to 95 percent of the cases].
    Berger N; Droz JP
    Rev Prat; 2007 Feb; 57(4):361-3. PubMed ID: 17455737
    [No Abstract]   [Full Text] [Related]  

  • 27. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
    Souchon R; Gertenbach U; Dieckmann KP; Hahn E; Ruwe M; Stambolis C; Loy V; Classen J
    Strahlenther Onkol; 2006 May; 182(5):289-92. PubMed ID: 16673063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
    Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
    J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on testis tumours.
    Berney DM
    Pathology; 2012 Aug; 44(5):419-26. PubMed ID: 22744174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changing presentation of germ cell tumours of the testis between 1983 and 2002.
    Powles TB; Bhardwa J; Shamash J; Mandalia S; Oliver T
    BJU Int; 2005 Jun; 95(9):1197-200. PubMed ID: 15892800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumours.
    Labropoulou VT; Theocharis AD; Ravazoula P; Perimenis P; Hjerpe A; Karamanos NK; Kalofonos HP
    Histopathology; 2006 Dec; 49(6):582-93. PubMed ID: 17163843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lymphoma or testicular seminoma: histopathological aspects of the differential diagnosis].
    Schill H; Terrier-Lacombe MJ
    Bull Cancer; 1993 Dec; 80(12):1058-62. PubMed ID: 8081043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.
    Venkitaraman R; Johnson B; Huddart RA; Parker CC; Horwich A; Dearnaley DP
    BJU Int; 2007 Jul; 100(1):30-2. PubMed ID: 17552950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis: a key effector mechanism of lymphocyte action in human nonseminomatous testicular carcinoma?
    Schmelz HU; Port M; Hauck EW; Schwerer MJ; Weidner W; Sparwasser C; Abend M
    BJU Int; 2005 Jul; 96(1):158-63. PubMed ID: 15963141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testicular pain as the initial presentation of testicular neoplasms.
    Wilson JP; Cooksey G
    Ann R Coll Surg Engl; 2004 Jul; 86(4):284-8. PubMed ID: 15239873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paratesticular localization of burned out non-seminomatous germ cell tumor--NSGCT: a case report.
    Rzeszutko M; Rzeszutko W; Nienartowicz E; Jeleń M
    Pol J Pathol; 2006; 57(1):55-7. PubMed ID: 16739885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
    Looijenga LH
    J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.